Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -10747.33x is 267% below its 5-year average of -2930.77x, near the high end of its 5-year range (-94795.00x–10042.00x).
As of the fiscal period ended Tuesday, September 30, 2025. 50.33% below its 12-month average of -7149.28x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2025 (2025-09-30): -10747.33x.
INTEREST COVERAGE RATIO
-10747.33x
INTEREST COVERAGE RATIO AVG TTM
-7149.28x
INTEREST COVERAGE RATIO AVG 3Y
-22029.07x
INTEREST COVERAGE RATIO AVG 5Y
-2930.77x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-50.33%
CURRENT VS 3Y AVG
+51.21%
CURRENT VS 5Y AVG
-266.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-168485.62%
vs the sector median at left
10x Genomics, Inc.
Market Cap
$10.19B
Interest Coverage Ratio
-10747.33x
TTM Avg
-7149.28x
3Y Avg
-22029.07x
5Y Avg
-2930.77x
Market Cap
$10.33B
Interest Coverage Ratio
N/A
TTM Avg
39.63x
3Y Avg
39.63x
5Y Avg
39.63x
Market Cap
$10.30B
Interest Coverage Ratio
-2.28x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.21B
Interest Coverage Ratio
4.07x
TTM Avg
9.27x
3Y Avg
11.38x
5Y Avg
10.77x
Market Cap
$10.21B
Interest Coverage Ratio
N/A
TTM Avg
67.41x
3Y Avg
66.08x
5Y Avg
407.22x
Market Cap
$10.55B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.03B
Interest Coverage Ratio
53.24x
TTM Avg
48.24x
3Y Avg
40.33x
5Y Avg
37.20x
Market Cap
$9.97B
Interest Coverage Ratio
2.57x
TTM Avg
2.57x
3Y Avg
27.60x
5Y Avg
20.53x
Market Cap
$9.94B
Interest Coverage Ratio
5.52x
TTM Avg
5.51x
3Y Avg
7.63x
5Y Avg
62.06x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 10x Genomics, Inc. (TXG) | $10.19B | -10747.33x | -7149.28x | -22029.07x | -2930.77x |
| Globus Medical, Inc. (GMED)vs › | $10.33B | N/A | 39.63x | 39.63x | 39.63x |
| ImmunityBio, Inc. (IBRX)vs › | $10.30B | -2.28x | N/A | N/A | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 4.07x | 9.27x | 11.38x | 10.77x |
| Align Technology, Inc. (ALGN)vs › | $10.21B | N/A | 67.41x | 66.08x | 407.22x |
| Twist Bioscience Corporation (TWST)vs › | $10.55B | N/A | N/A | N/A | N/A |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 53.24x | 48.24x | 40.33x | 37.20x |
| Repligen Corporation (RGEN)vs › | $9.97B | 2.57x | 2.57x | 27.60x | 20.53x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.94B | 5.52x | 5.51x | 7.63x | 62.06x |
| Universal Health Services, Inc. (UHS)vs › | $10.75B | 12.68x | 10.82x | 8.80x | 10.61x |
Interest Coverage
-10747.3x
Debt/Equity
0.10
Current Ratio
5.69
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-09-30 | -10747.33x |
| 2025-06-30 | 10042.00x |
| 2024-09-30 | -20742.50x |
| 2024-06-30 | -41737.00x |
| 2024-03-31 | -61498.00x |
| 2023-12-31 | -6898.50x |
| 2023-09-30 | -94795.00x |
| 2023-06-30 | -12671.60x |
| 2023-03-31 | -2736.21x |
| 2022-12-31 | -184.77x |
| 2022-09-30 | -350.84x |
| 2022-06-30 | -579.06x |
| 2022-03-31 | -326.05x |
| 2021-12-31 | -72.95x |
| 2021-09-30 | -72.51x |
| 2021-06-30 | -49.42x |
| 2021-03-31 | -46.23x |
| 2020-12-31 | -1292.06x |
| 2020-09-30 | -164.37x |
| 2020-06-30 | -128.82x |
| 2020-03-31 | -30.04x |
| 2019-12-31 | -8.15x |
| 2019-09-30 | -12.85x |
| 2019-06-30 | -14.91x |
| 2019-03-31 | -4.44x |
| 2018-12-31 | -108.96x |
| 2018-09-30 | -22.66x |
